NewKerala.com

Key Points

A groundbreaking study has uncovered how the malaria parasite Plasmodium falciparum can lead to Burkitt lymphoma, a common childhood cancer in equatorial regions. Researchers found that the parasite significantly elevates an enzyme called AID in B cells, which can trigger critical genetic mutations. The study reveals that areas with consistent malaria presence have 10 times higher lymphoma rates compared to other regions. This research offers potential insights into reducing childhood cancer risk through malaria prevention strategies.

Key Points: Malaria Parasite Linked to Childhood Burkitt Lymphoma Cancer

  • Malaria parasite triggers genetic mutations in immune B cells
  • AID enzyme elevation linked to cancer development
  • Study focuses on children in malaria-prevalent regions
  • P. falciparum uniquely associated with lymphoma risk
2 min read

Study decodes how malaria can lead to childhood cancer

US researchers reveal how Plasmodium falciparum malaria triggers genetic mutations leading to Burkitt lymphoma in children

"Knowing that malaria has a direct role in increasing childhood cancer risk means that measures to reduce the burden of P. falciparum malaria could also reduce the incidence of Burkitt lymphoma - Dr. Rosemary Rochford"

New Delhi, April 25

US researchers have uncovered the role of Plasmodium falciparum -- a parasitic protozoan that causes malaria -- in the development of Burkitt lymphoma (BL), the most common childhood cancer.

BL is a cancer that affects B cells -- an important cell of the immune system that produces antibodies. It has been associated with P. falciparum malaria since 1958, but the underlying mechanism of how this leads to cancer has remained a mystery.

While BL is a rare cancer globally, (found more in equatorial Africa and New Guinea) its prevalence is 10 times higher in areas with a consistent presence of P. falciparum malaria.

Five different species of Plasmodium can cause malaria in humans, but only P. falciparum is associated with BL.

“Knowing that malaria has a direct role in increasing childhood cancer risk means that measures to reduce the burden of P. falciparum malaria could also reduce the incidence of Burkitt lymphoma,” said Dr. Rosemary Rochford, Professor of Immunology and Microbiology at the University of Colorado Anschutz School of Medicine.

The study, published in The Journal of Immunology, found significant elevated expression of an enzyme called AID (activation-induced cytidine deaminase) in B cells during P. falciparum malarial infection in children.

Further, they found that a hallmark of BL is the translocation of a gene called MYC -- a genetic mutation where DNA breaks off one chromosome and attaches to another.

The enzyme AID is essential for MYC translocation, which is why its presence in malaria patients indicates P. falciparum malaria’s role in BL, said the team.

For the study, they assessed blood from children with uncomplicated malaria for AID levels and compared them to children without malaria.

Uncomplicated malaria is when a patient’s symptoms are non-specific, including fever, chills, sweating, headache, nausea, and/or vomiting, without signs of severe organ dysfunction.

AID was significantly elevated in B cells of children with uncomplicated malaria and found to be fully functional. The functionality of the excess AID also supports the role of P. falciparum in causing BL.

“This study adds to the body of literature pointing to a critical role of the enzyme, AID, in the aetiology of Burkitt lymphoma and potentially in other non-Hodgkin’s lymphomas,” Rochford said.

- IANS

Share this article:

Reader Comments

S
Sarah K.
This is fascinating research! It's incredible how malaria's effects go beyond the immediate illness. Hope this leads to better prevention strategies for both malaria and childhood cancers. 🙏
J
James L.
The article mentions this is most prevalent in equatorial Africa - does this mean malaria vaccines could potentially reduce cancer rates there too? Would love to see follow-up studies on that connection.
A
Aisha M.
As someone from Nigeria, this hits close to home. We've known malaria is dangerous, but the cancer link is terrifying. More reason to push for better mosquito control and healthcare access.
T
Thomas R.
Interesting study, but I wish the article explained more about why only P. falciparum causes this effect when there are other malaria-causing parasites. The mechanism seems specific but isn't fully clear.
P
Priya S.
The science behind this is mind-blowing! From malaria parasite to enzyme activity to genetic mutations... Our bodies are so complex. Major props to the researchers who untangled this connection.
M
Miguel G.
This makes me wonder - could monitoring AID levels in malaria patients help identify kids at higher cancer risk early? That could be a game-changer for early detection and treatment.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50